BENLYSTA

NDC 49401-101 · GlaxoSmithKline LLC

Generic namebelimumab

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)BELIMUMAB

Strength120 mg/1.5mL

Pharmacologic classB Lymphocyte Stimulator-directed Antibody Interactions [MoA], B Lymphocyte Stimulator-specific Inhibitor [EPC], Decreased B Lymphocyte Activation [PE]

Marketing categoryBLA

Packages

49401-101-01 — 1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL

Billed under HCPCS

J0490 — Injection, belimumab, 10 mg Medicare Part B payment limit (ASP + 6%): $58.30

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

49401-088 — belimumab, 49401-102 — belimumab

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.